Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma
Current standard of care for glioblastoma is surgical resection followed by temozolomide chemotherapy and radiation. Recent studies have demonstrated that >95% extent of resection is associated with better outcomes, including prolonged progression-free and overall survival. The diffusely infi...
Main Authors: | Linda M. Wang, Matei A. Banu, Peter Canoll, Jeffrey N. Bruce |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.666734/full |
Similar Items
-
Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic
by: Francesco Guerrini, et al.
Published: (2022-05-01) -
A Systematic Review and Meta-Analysis of Supramarginal Resection versus Gross Total Resection in Glioblastoma: Can We Enhance Progression-Free Survival Time and Preserve Postoperative Safety?
by: Johannes Wach, et al.
Published: (2023-03-01) -
Fluorescein-guided surgery for high-grade glioma resection: a five-year-long retrospective study at our institute
by: Chen Xi, et al.
Published: (2023-06-01) -
A Systematic Review of Amino Acid PET Imaging in Adult-Type High-Grade Glioma Surgery: A Neurosurgeon’s Perspective
by: Raffaele De Marco, et al.
Published: (2022-12-01) -
Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome
by: Karl-Michael Schebesch, et al.
Published: (2022-01-01)